Physician profile
Daniel J Olson
NPI 1255395224
$8,164.88
in general payments reported to CMS, 2019-2025
31 companies · $1,085 in 2025
The $1,085 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,003 · 2020: $514 · 2021: $1,427 · 2022: $909 · 2023: $693 · 2024: $534 · 2025: $1,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,296 · Education: $16.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,296.15 |
| Education | $16.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,352.28 | 2019-2025 | Grafix Pl, Stravix Pl, Stravix Mesh |
| Organogenesis INC. | $1,392.31 | 2019-2025 | Puraply Wound Matrix, Apligraf, Affinity |
| Wright Medical Technology, INC. | $1,057.36 | 2019 | |
| Mid-Atlantic Surgical Systems, LLC | $812.14 | 2019 | |
| Arthrex, INC. | $516.00 | 2019 | |
| Horizon Therapeutics Plc | $253.72 | 2019-2023 | Krystexxa |
| Medtronic, INC. | $229.22 | 2021-2025 | Inceptiv |
| Paratek Pharmaceuticals, INC. | $205.47 | 2023-2025 | Nuzyra |
| Bioventus LLC | $196.98 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Boston Scientific Corporation | $177.57 | 2021-2022 | |
| Treace Medical Concepts, INC. | $142.20 | 2025 | |
| Misonix INC | $113.83 | 2020-2021 | |
| Stryker Corporation | $99.02 | 2020-2025 | Citrefix, Augment Injectable, 7 X 23mm Citrelock Implant |
| Averitas Pharma INC. | $88.67 | 2024-2025 | Qutenza |
| Kerecis Limited | $75.74 | 2019-2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $66.63 | 2019-2021 | |
| Amgen INC. | $58.60 | 2025 | Krystexxa |
| Reprise Biomedical, INC. | $48.81 | 2025 | Miro3d, Miro 3d |
| Polynovo North America LLC | $48.37 | 2022-2023 | |
| Pfizer INC. | $38.53 | 2019-2025 | |
| Nabriva Therapeutics, Plc | $32.78 | 2021 | |
| Osiris Therapeutics INC. | $24.12 | 2019 | |
| Kci USA, INC. | $20.45 | 2020 | |
| Triad Life Sciences INC. | $19.17 | 2022 | |
| Hartmann USA, INC. | $15.45 | 2024 | Zetuvit Plus 10x10 P10 |
| Vertex Pharmaceuticals Incorporated | $14.43 | 2025 | |
| Urgo Medical North America, LLC | $14.31 | 2025 | Urgoclean Ag |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.77 | 2021 | |
| Axogen | $13.22 | 2019 | |
| Advanced Oxygen Therapy INC. | $12.74 | 2022 | |
| Merck Sharp & Dohme LLC | $10.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.